IL15 and ovarian carcinoma: We further developed CD16Hi Vδ2 T cells for cancer therapy through CAR and IL-15 engineering and confirmed by in vitro and in vivo characterization that CAR15-Vδ2 T cells display robust antitumor efficacy against ovarian cancer models.